上海医药:艾司奥美拉唑镁肠溶胶囊获批生产

财中社
Sep 28

9月28日,上海医药(601607/02607)发布公告,公司下属常州制药厂有限公司收到国家药品监督管理局颁发的艾司奥美拉唑镁肠溶胶囊的《药品注册证书》,该药品获得批准生产。该药品规格为20mg和40mg,注册分类为化学药品3类。  截至公告日,公司针对该药品已投入研发费用约519万元。根据数据显示,2025年中国大陆医院采购艾司奥美拉唑镁肠溶胶囊的金额为6.39亿元。  2026年中期,上海医药...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10